January 10, 2025

Mediar Therapeutics Enters into Global Licensing Agreement with Lilly to Advance First-in-Class WISP1 Antibody for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) – PR Newswire

January 9, 2025

Comparing multi-texture fibrosis analysis versus binary opacity-based abnormality detection for quantitative assessment of idiopathic pulmonary fibrosis – Nature.com

January 3, 2025

Common biomarkers of idiopathic pulmonary fibrosis and systemic sclerosis based on WGCNA and machine learning – Nature.com

January 2, 2025

Prognostic value of [18F]FDG PET/CT in patients with idiopathic pulmonary fibrosis | Scientific Reports – Nature.com

Prognostic value of [18F]FDG PET/CT in patients with idiopathic pulmonary fibrosis | Scientific Reports

December 28, 2024

The density histograms-derived computerized integrated index (CII) predicts mortality in idiopathic pulmonary fibrosis – Nature.com